New study aims to unlock secrets of hepatitis d treatment success
NCT ID NCT07313358
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study looks at data and samples from 220 people with hepatitis D (HDV) who are already taking the medication bulevirtide. Researchers want to see how well the drug works over time and find markers that predict a good response. The goal is to improve monitoring and care for people with this chronic liver infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HDV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Heinrich Heine University
Düsseldorf, Germany, 40225, Germany
-
Università di Milano
Milan, Italy, 20122, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.